Correlation Between SAB Biotherapeutics and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and TC BioPharm Holdings, you can compare the effects of market volatilities on SAB Biotherapeutics and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and TC BioPharm.

Diversification Opportunities for SAB Biotherapeutics and TC BioPharm

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SAB and TCBP is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and TC BioPharm go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and TC BioPharm

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 2.65 times more return on investment than TC BioPharm. However, SAB Biotherapeutics is 2.65 times more volatile than TC BioPharm Holdings. It trades about 0.01 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.5 per unit of risk. If you would invest  7.20  in SAB Biotherapeutics on September 4, 2024 and sell it today you would lose (2.03) from holding SAB Biotherapeutics or give up 28.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy95.0%
ValuesDaily Returns

SAB Biotherapeutics  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
SAB Biotherapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
TC BioPharm Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

SAB Biotherapeutics and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SAB Biotherapeutics and TC BioPharm

The main advantage of trading using opposite SAB Biotherapeutics and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind SAB Biotherapeutics and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Valuation
Check real value of public entities based on technical and fundamental data